Purchase Order HHSN263201600668A

The Office of Logistics and Acquisition Operations awarded a $33,229.90 firm fixed price purchase order to Qiagen, LLC for preventative maintenance and service of onsite laboratory instruments. The contract, which is not set-aside designated, was awarded on April 15, 2026, with an ultimate completion date of April 14, 2027, and will be performed in Bethesda, Maryland. As a child contract under a larger vehicle, this purchase order leverages Qiagen's established position as a preferred supplier...

<p>The Office of Logistics and Acquisition Operations awarded a purchase order to Qiagen, LLC for $15,000 on July 16, 2019, for the supply of IVA 5000 samples upload. Performance takes place in Germantown, Maryland with a firm fixed price structure and an ultimate completion date of August 15, 2019.</p>

<p>The Office of Logisitics and Acquisition Operations issued a purchase order to Qiagen, LLC on August 13, 2018, for IPA LNUL and CLC license maintenance, with a ceiling value of $11,443.25.</p> <p>Performance occurs in Bethesda, Maryland. The order carries an ultimate completion date of March 5, 2019. No set-aside applies. The purchase order is firm fixed price.</p>

The U.S. Office of Logistics and Acquisition Operations awarded a firm fixed-price purchase order valued at $8,204.62 to Qiagen, LLC for chemicals on December 3, 2024, with an ultimate completion date of December 3, 2026. The award, which carries no set-aside designation, reflects Qiagen's demonstrated capability to compete effectively in the open federal marketplace. Performance will take place at the company's Germantown, Maryland headquarters, where Qiagen maintains substantial operations...

<p>The Defense Health Agency issued a purchase order to Qiagen, LLC for a genomics scientific analysis software license valued at $49,862.00, awarded May 30, 2025, with an ultimate completion date of May 31, 2030. The order covers no set-aside and carries firm fixed-price terms. Performance takes place in Silver Spring, Maryland.</p>

This firm fixed-price purchase order is for maintenance and renewal services for software, valued at $19,229.00. The award was made by the National Institutes of Health (NIH) Clinical Center, a civilian agency, to Qiagen, LLC, a division of the international medical technology company Qiagen N.V. Qiagen has provided a range of products and services to support biomedical research, public health, law enforcement, and healthcare programs for various federal agencies, including the Department of...

The U.S. government awarded a $64,803.10 firm fixed-price purchase order to Qiagen, LLC on August 1, 2024, for IPA Analysis Match Explorer add-user licensing in production environments. This contract, which is a child order under a larger vehicle, will be performed in Germantown, Maryland, where Qiagen maintains its headquarters, with an ultimate completion date of March 2, 2029. The award was made by a civilian federal agency within the Northeast Area and did not utilize a set-aside...

Qiagen, LLC has been awarded a firm fixed price purchase order valued at $19,237.01 by the NIH Clinical Center for QIAGEN Ingenuity Pathway Analysis software. The award, issued September 4, 2025, carries an ultimate completion date of October 4, 2025. This contract represents a direct procurement with no set-aside designation, reflecting Qiagen's competitive standing in the open federal marketplace. The place of performance is Germantown, Maryland, where Qiagen maintains its U.S. headquarters....

The Department of Health and Human Services (HHS) National Institutes of Health (NIH) Clinical Center awarded a $17,600.00 firm fixed price purchase order to Qiagen, LLC, a division of the international life sciences company Qiagen N.V. The contract is for the renewal of a data analysis software license and has a completion date of March 30, 2025. Qiagen is a provider of sample and assay technologies that supports federal agencies' biomedical research, public health, law enforcement, and...

This is a $16,030.84 firm fixed-price purchase order contract awarded by the National Institutes of Health (NIH) Clinical Center to Qiagen, LLC, a foreign-owned, for-profit manufacturer of molecular diagnostics, scientific equipment, and bioinformatics solutions. The contract is for the procurement of licensing for web access to Qiagen's Ingenuity Pathway Analysis software. This contract was not set aside and does not appear to be associated with a larger contract vehicle. Qiagen has a history...